• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Magyar Telekom

Magyar Telekom

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Magyar Telekom Improves 2014 Ebitda View as 2Q Beats Expectations

    Magyar Telekom Improves 2014 Ebitda View as 2Q Beats Expectations

  2. Magyar Telekom Can't Commit to Resuming Dividend on 2014 Earnings -CFO

    Magyar Telekom Can't Commit to Resuming Dividend on 2014 Earnings -CFO

  3. FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis

    FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis

  4. UPDATE: Want to buy some air? Some cities have plenty to sell

    UPDATE: Want to buy some air? Some cities have plenty to sell

  5. CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014

    CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014

  6. CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands

    CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands

  7. IMF Says Growth in Eastern Europe will be Marginal in 2011

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.